EP Patent

EP2310001A2 — Transdermal estrogen device and delivery

Assigned to Noven Pharmaceuticals Inc · Expires 2011-04-20 · 15y expired

What this patent protects

Described arc transdermal drug delivery systems for the transdermal administration of estrogen, comprising a polymer matrix and estrogen. Methods of making and using such systems also are described.

USPTO Abstract

Described arc transdermal drug delivery systems for the transdermal administration of estrogen, comprising a polymer matrix and estrogen. Methods of making and using such systems also are described.

Drugs covered by this patent

Patent Metadata

Patent number
EP2310001A2
Jurisdiction
EP
Classification
—
Expires
2011-04-20
Drug substance claim
No
Drug product claim
No
Assignee
Noven Pharmaceuticals Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.